Objective
To characterize tocolytic use and examine perinatal outcomes among women presenting very preterm with spontaneous labor and cervical dilation ≥4 cm.
Methods
This was a retrospective cohort study. Data from January 2000 to June 2011 in a single healthcare system were reviewed. Women with singleton, non-anomalous fetuses, and preterm labor with intact membranes between 23.0–32.0 weeks gestation who had cervical dilation ≥4 cm and <8 cm at admission were included. Women receiving one or more tocolytics (magnesium sulfate, indomethacin, or nifedipine) were compared to those who did not receive tocolysis. The primary outcome was composite major neonatal morbidity.
Results
Two hundred ninety seven women were included; 233 (78.5%) received at least one tocolytic. Women receiving tocolysis were slightly less dilated (median 5 vs. 6 cm, p<0.001) at presentation, and were more likely to receive at least a partial course of corticosteroids (88.4% vs. 56.3%, p<0.001). Initial composite severe neonatal morbidity rates were similar (41.6% vs. 43.8%, p=0.761) regardless of tocolytic administration. Those receiving tocolysis were significantly more likely to be pregnant at least 48 hours after admission (23.6% vs. 7.8%, p=0.005), but a similar proportion delivered within 7 days of admission (94.8% vs. 95.3%, p>0.99), and delivery gestational ages were similar (28.9 vs. 29.2 weeks, p=0.408). The incidence of chorioamnionitis and postpartum endometritis were similar between groups.
Conclusion
The majority of women presenting very preterm with advanced cervical dilation received tocolysis. Although tocolysis administration increased the likelihood of achieving at least 48 hours of latency, initial neonatal outcomes were similar.